Proteogenomic Characterization of Endometrial Carcinoma

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · see citing works

Trimmomatic: a flexible trimmer for Illumina sequence data

Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548 · see citing works

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works

Fast gapped-read alignment with Bowtie 2

Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · see citing works

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179 · see citing works

Cancer statistics, 2019

Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works

Cancer statistics, 2018

Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632 · see citing works

GSVA: gene set variation analysis for microarray and RNA-Seq data

Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · see citing works

Fast and accurate long-read alignment with Burrows-Wheeler transform.

Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063 · see citing works

Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets

Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855 · see citing works

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · see citing works

Molecular mechanisms of epithelial–mesenchymal transition

Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · see citing works

Circular RNAs are a large class of animal RNAs with regulatory potency

Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990 · see citing works

UniProt: a worldwide hub of protein knowledge

The UniProt Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1049 · Cited by 7,698 · see citing works

XGBoost: A Scalable Tree Boosting System

Chen, T., & Guestrin, C. (2016) · arXiv · doi:10.48550/arxiv.1603.02754 · Cited by 7,104 · see citing works

Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining

(2016) · doi:10.1145/2939672 · Cited by 6,563 · see citing works

Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation

O'Leary, N. A., Wright, M. W., Brister, J. R., Ciufo, S., Haddad, D., McVeigh, R., Rajput, B., Robbertse, B., Smith-White, B., Ako-Adjei, D., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1189 · Cited by 6,357 · see citing works

Integrated genomic characterization of endometrial carcinoma

The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784 · see citing works

The Reactome pathway Knowledgebase

Fabregat, A., Sidiropoulos, K., Garapati, P. V., Gillespie, M. E., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,568 · see citing works

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041 · see citing works

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,838 · see citing works

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint

Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,822 · see citing works

EMT: 2016

Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492 · see citing works

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Samstein, R. M., Lee, C.-H., Shoushtari, A. N., Hellmann, M. D., Shen, R., Janjigian, Y. Y., Barron, D. A., Zehir, A., Jordan, E. J., Omuro, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0312-8 · Cited by 4,071 · see citing works

Lysine acetylation targets protein complexes and co-regulates major cellular functions

Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040 · see citing works

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,869 · see citing works

Fast gene set enrichment analysisPreprint

Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,742 · see citing works

Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints

Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317 · see citing works

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201 · see citing works

WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs

Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144 · see citing works

ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage

Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · see citing works

The Reactome Pathway Knowledgebase

Fabregat, A., Jupe, S., Matthews, L. R., Sidiropoulos, K., Gillespie, M. E., Garapati, P. V., Haw, R., Jassal, B., Korninger, F., May, B., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1132 · Cited by 2,798 · see citing works

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Vasaikar, S. V., Straub, P., Wang, J., & Zhang, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1090 · Cited by 2,324 · see citing works

Comprehensive Characterization of Cancer Driver Genes and Mutations

Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,316 · see citing works

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Goodman, A. M., Kato, S., Bazhenova, L., Patel, S. P., Frampton, G. M., Miller, V., Stephens, P. J., Daniels, G. A., & Kurzrock, R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0386 · Cited by 2,264 · see citing works

The RNA Binding Protein Quaking Regulates Formation of circRNAs

Conn, S. J., Pillman, K. A., Toubia, J., Conn, V. M., Salmanidis, M., Phillips, C. A., Roslan, S., SCHREIBER, A. W., Gregory, P. A., & Goodall, G. J. (2015) · Cell · doi:10.1016/j.cell.2015.02.014 · Cited by 2,187 · see citing works

Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs

Zheng, Q., Bao, C., Guo, W., Li, S., Chen, J., Chen, B., Luo, Y., Lyu, D., Li, Y., Shi, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms11215 · Cited by 2,045 · see citing works

A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes

Miranda, K. C., Huynh, T., Tay, Y., Ang, Y.-S., Tam, W. L., Thomson, A. M., Lim, B., & Rigoutsos, I. (2006) · Cell · doi:10.1016/j.cell.2006.07.031 · Cited by 2,020 · see citing works

Absolute quantification of somatic DNA alterations in human cancer

Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T. I., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,003 · see citing works

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

Ye, K., Schulz, M. H., Long, Q., Apweiler, R., & Ning, Z. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp394 · Cited by 1,978 · see citing works

miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions

Chou, C., Shrestha, S., Yang, C.-D., Chang, N.-W., Lin, Y., Liao, K., Huang, W.-C., Sun, T.-H., Tu, S.-J., Lee, W.-H., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1067 · Cited by 1,813 · see citing works

The Landscape of Circular RNA in Cancer

Vo, J. N., Cieslik, M. P., Zhang, Y., Shukla, S. K., Xiao, L., Zhang, Y., Wu, Y., Dhanasekaran, S. M., Engelke, C. G., Cao, X., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.021 · Cited by 1,746 · see citing works

miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes

Dweep, H., Sticht, C., Pandey, P., & Gretz, N. (2011) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2011.05.002 · Cited by 1,699 · see citing works

Toward a Shared Vision for Cancer Genomic Data

Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1607591 · Cited by 1,680 · see citing works

Proteogenomics connects somatic mutations to signalling in breast cancer

CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676 · see citing works

Chk1 is an essential kinase that is regulated by Atr and required for the G ₂ /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625 · see citing works

Endometrial cancer

Amant, F. C., Moerman, P., Neven, P., Timmerman, D., Limbergen, E. V., & Vergote, I. B. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67063-8 · Cited by 1,613 · see citing works

Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs

Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,589 · see citing works

A probability-based approach for high-throughput protein phosphorylation analysis and site localization

Beausoleil, S. A., Villén, J., Gerber, S. A., Rush, J., & Gygi, S. P. (2006) · Nature Biotechnology · doi:10.1038/nbt1240 · Cited by 1,577 · see citing works

NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

Jurtz, V. I., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,476 · see citing works

Proteogenomic characterization of human colon and rectal cancer

CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., et al. (2014) · Nature · doi:10.1038/nature13438 · Cited by 1,462 · see citing works

miRTarBase: a database curates experimentally validated microRNA–target interactions

Hsu, S.-D., Lin, F., Wu, W.-Y., Liang, C., Huang, W.-C., Chan, W.-L., Tsai, W.-T., Chen, G.-Z., Lee, C.-J., Chiu, C.-M., et al. (2010) · Nucleic Acids Res. · doi:10.1093/nar/gkq1107 · Cited by 1,387 · see citing works

A Road Map for Those Who Don't Know JAK-STAT

Aaronson, D. S., & Horvath, C. M. (2002) · Science · doi:10.1126/science.1071545 · Cited by 1,339 · see citing works

Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations

Shin, D. S., Zaretsky, J. M., Escuin-Ordinas, H., Garcia-Diaz, A., Hu-Lieskovan, S., Kalbasi, A., Grasso, C. S., Hugo, W., Sandoval, S., Torrejon, D. Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1223 · Cited by 1,337 · see citing works

Circular RNAs in cancer: opportunities and challenges in the field

Kristensen, L. S., Hansen, T. B., Venø, M. T., & Kjems, J. (2017) · Oncogene · doi:10.1038/onc.2017.361 · Cited by 1,328 · see citing works

The growing landscape of lysine acetylation links metabolism and cell signalling

Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E., & Mann, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3841 · Cited by 1,324 · see citing works

Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase

Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322 · see citing works

CORUM: the comprehensive resource of mammalian protein complexes—2009

Ruepp, A., Wägele, B., Lechner, M., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C., & Mewes, H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp914 · Cited by 1,320 · see citing works

Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2

Walker, J. L., Piedmonte, M. R., Spirtos, N. M., Eisenkop, S. M., Schlaerth, J. B., Mannel, R. S., Spiegel, G., Barakat, R., Pearl, M. L., & Sharma, S. K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3248 · Cited by 1,288 · see citing works

JAK-STAT Signaling: From Interferons to Cytokines

Schindler, C., Levy, D. E., & Decker, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700016200 · Cited by 1,263 · see citing works

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Chen, Y., Scanlan, M. J., Şahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M. G., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247 · see citing works

CIRI: an efficient and unbiased algorithm for de novo circular RNA identification

Gao, Y., Wang, J., & Zhao, F. (2015) · Genome biology · doi:10.1186/s13059-014-0571-3 · Cited by 1,118 · see citing works

Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis

Yang, Y., Gao, X., Zhang, M., Yan, S., Sun, C., Xiao, F., Huang, N., Yang, X., Zhao, K., Zhou, H., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx166 · Cited by 1,108 · see citing works

Perturbation-response genes reveal signaling footprints in cancer gene expression

(2017) · doi:10.1038/s41467-017-02391-6 · Cited by 1,108 · see citing works

MS-GF+ makes progress towards a universal database search tool for proteomics

Kim, S., & Pevzner, P. A. (2014) · Nature Communications · doi:10.1038/ncomms6277 · Cited by 1,098 · see citing works

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome

Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069 · see citing works

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029 · see citing works

Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer

Talhouk, A., McConechy, M. K., Leung, S. C. Y., Yang, W., Lum, A. M., Senz, J., Boyd, N., Pike, J. A., Anglesio, M. S., Kwon, J. S., et al. (2017) · Cancer · doi:10.1002/cncr.30496 · Cited by 992 · see citing works

metaX: a flexible and comprehensive software for processing metabolomics data

Wen, B., Mei, Z., Zeng, C., & Liu, S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1579-y · Cited by 987 · see citing works

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer

Krebs, A. M., Mitschke, J., Losada, M. L., Schmalhofer, O., Boerries, M., Busch, H. S., Böttcher, M., Mougiakakos, D., Reichardt, W., Bronsert, P., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3513 · Cited by 979 · see citing works

Circular RNA and miR-7 in Cancer

Hansen, T. B., Kjems, J. K., & Damgaard, C. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1568 · Cited by 921 · see citing works

Functional normalization of 450k methylation array data improves replication in large cancer studies

Fortin, J.-P., Labbe, A., Lemire, M., Zanke, B. W., Hudson, T. J., Fertig, E. J., Greenwood, C. M. T., & Hansen, K. D. (2014) · Genome biology · doi:10.1186/s13059-014-0503-2 · Cited by 893 · see citing works

DGIdb 3.0: a redesign and expansion of the drug–gene interaction database

Cotto, K. C., Wagner, A. H., Feng, Y.-Y., Kiwala, S., Coffman, A. C., Spies, G., Wollam, A., Spies, N. C., Griffith, O. L., & Griffith, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1143 · Cited by 888 · see citing works

MSIsensor: microsatellite instability detection using paired tumor-normal sequence data

Niu, B., Ye, K., Zhang, Q., Lu, C., Xie, M., McLellan, M. D., Wendl, M. C., & Ding, L. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt755 · Cited by 821 · see citing works

Ribosome biogenesis in cancer: new players and therapeutic avenues

Pelletier, J., Thomas, G., & Volarević, S. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.104 · Cited by 802 · see citing works

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

Vasaikar, S., Huang, C., Wang, X., Petyuk, V. A., Savage, S. R., Wen, B., Dou, Y., Zhang, Y., Shi, Z., Arshad, O. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.030 · Cited by 799 · see citing works

OptiType: precision HLA typing from next-generation sequencing data

Szolek, A., Schubert, B., Mohr, C., Sturm, M., Feldhahn, M., & Kohlbacher, O. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu548 · Cited by 778 · see citing works

Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery

Macůrek, L., Lindqvist, A., Lim, D., Lampson, M. A., Klompmaker, R., Freire, R., Clouin, C., Taylor, S. S., Yaffe, M. B., & Medema, R. H. (2008) · Nature · doi:10.1038/nature07185 · Cited by 710 · see citing works

A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries

Fisher, S., Barry, A. J., Abreu, J., Minie, B., Nolan, J., Delorey, T. M., Young, G., Fennell, T. J., Allen, A., Ambrogio, L., et al. (2011) · Genome biology · doi:10.1186/gb-2011-12-1-r1 · Cited by 683 · see citing works

MuSiC: Identifying mutational significance in cancer genomesPreprint

Dees, N. D., Zhang, Q., Kandoth, C., Wendl, M. C., Schierding, W. S., Koboldt, D. C., Mooney, T. B., Callaway, M. B., Dooling, D. J., Mardis, E. R., et al. (2012) · Genome Research · doi:10.1101/gr.134635.111 · Cited by 669 · see citing works

First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication

Lemery, S. J., Keegan, P., & Pazdur, R. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1709968 · Cited by 664 · see citing works

OmniPath: guidelines and gateway for literature-curated signaling pathway resources

Türei, D., Korcsmaros, T. D., & Sáez-Rodríguez, J. (2016) · Nature Methods · doi:10.1038/nmeth.4077 · Cited by 660 · see citing works

Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening

McDonald, E. R., de Weck, A., Schlabach, M. R., Billy, E., Mavrakis, K. J., Hoffman, G. R., Belur, D., Castelletti, D., Frias, E., Gampa, K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.005 · Cited by 658 · see citing works

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Li, S., Shen, D., Shao, J., Crowder, R. J., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 623 · see citing works

ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance

Zhang, P., Sun, Y., & Ma, L. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1006048 · Cited by 611 · see citing works

ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing

Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., & Carstens, R. P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.025 · Cited by 570 · see citing works

The CPTAC Data Portal: A Resource for Cancer Proteomics Research

Edwards, N. J., Oberti, M., Thangudu, R. R., Cai, S., McGarvey, P. B., Jacob, S., Madhavan, S., & Ketchum, K. A. (2015) · Journal of Proteome Research · doi:10.1021/pr501254j · Cited by 565 · see citing works

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

Gao, Q.-S., Liang, W.-W., Foltz, S., Mutharasu, G., Jayasinghe, R., Cao, S., Liao, W.-W., Reynolds, S., Wyczalkowski, M., Yao, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.050 · Cited by 557 · see citing works

Widespread and Functional RNA Circularization in Localized Prostate Cancer

Chen, S., Huang, V., Xu, X., Livingstone, J., Soares, F., Jeon, J., Zeng, Y., Hua, J. T., Petricca, J., Guo, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.025 · Cited by 544 · cited 2× · see citing works

NCBI’s Database of Genotypes and Phenotypes: dbGaP

Tryka, K. A., Hao, L., Sturcke, A., Jin, Y., Wang, Z. Y., Ziyabari, L., Lee, M., Popova, N. V., Sharopova, N., Kimura, M., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1211 · Cited by 531 · see citing works

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

Mak, M. P., Tong, P., Diao, L., Cardnell, R. J., Gibbons, D. L., William, W. N., Skoulidis, F., Parra, E. R., Rodriguez‐Canales, J., Wistuba, I. I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0876 · Cited by 526 · see citing works

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer: a TransPORTEC initiative.

Stelloo, E., Bosse, T., Nout, R. A., MacKay, H. J., Church, D. N., Nijman, H. W., Leary, A., Edmondson, R. J., Powell, M. E., Crosbie, E. J., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.43 · Cited by 486 · see citing works

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

de Almeida, L. G. P., Sakabe, N. J., deOliveira, A. R., da Silva, M. C. C., Mundstein, A. S., Cohen, T., Chen, Y., Chua, R., Gurung, S., Gnjatic, S., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn673 · Cited by 436 · see citing works

Spectral Probabilities and Generating Functions of Tandem Mass Spectra: A Strike against Decoy Databases

Kim, S., Gupta, N., & Pevzner, P. A. (2008) · Journal of Proteome Research · doi:10.1021/pr8001244 · Cited by 412 · see citing works

The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes

Kim, T., Laird, P. W., & Park, P. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.015 · Cited by 379 · see citing works

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity

Bajrami, I., Frankum, J. R., Konde, A., Miller, R. E., Rehman, F. L., Brough, R., Campbell, J., Sims, D., Rafiq, R., Hooper, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2541 · Cited by 373 · see citing works

A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

Hollenbach, P. W., Nguyen, A. N., Brady, H. A., Williams, M. M., Ning, Y., Richard, N., Krushel, L. A., Aukerman, S. L., Heise, C. C., & MacBeth, K. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009001 · Cited by 362 · see citing works

CORUM: the comprehensive resource of mammalian protein complexes

Ruepp, A., Brauner, B., Dunger-Kaltenbach, I., Frishman, G., Montrone, C., Stransky, M., Wägele, B., Schmidt, T., Doudieu, O. N., Stümpflen, V., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm936 · Cited by 351 · see citing works

β-Catenin—A Linchpin in Colorectal Carcinogenesis?

Wong, N. A. C. S., & Pignatelli, M. N. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64856-0 · Cited by 341 · see citing works

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence

Kurnit, K. C., Kim, G. N., Fellman, B. M., Urbauer, D. L., Mills, G. B., Zhang, W., & Broaddus, R. R. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.15 · Cited by 325 · see citing works

Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

Harel, M., Ortenberg, R., Varanasi, S. K., Mangalhara, K. C., Mardamshina, M., Markovits, E., Baruch, E. N., Tripple, V., Arama-Chayoth, M., Greenberg, E., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.012 · Cited by 323 · see citing works

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Nordeen, S. K., & Richer, J. K. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1046 · Cited by 322 · see citing works

MLH1 Promoter Methylation and Gene Silencing is the Primary Cause of Microsatellite Instability in Sporadic Endometrial Cancers

Simpkins, S. B., Bocker, T., Swisher, E. M., Mutch, D. G., Gersell, D. J., Kovatich, A. J., Palazzo, J., Fishel, R. A., & Goodfellow, P. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.661 · Cited by 319 · see citing works

The Regulatory Role of MicroRNAs in EMT and Cancer

Zaravinos, A. (2015) · Journal of Oncology · doi:10.1155/2015/865816 · Cited by 293 · see citing works

STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-SeqPreprint

Haas, B. J., Dobin, A., Stransky, N., Li, B., Yang, X. F., Tickle, T. L., Bankapur, A., Ganote, C. L., Doak, T. G., Pochet, N. L. M. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/120295 · Cited by 284 · see citing works

Cilium assembly and disassembly

Sánchez, I., & Dynlacht, B. D. (2016) · Nature Cell Biology · doi:10.1038/ncb3370 · Cited by 279 · see citing works

Automatic Relevance Determination in Nonnegative Matrix Factorization with the /spl beta/-Divergence

Tan, V. Y. F., & Févotte, C. (2012) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2012.240 · Cited by 271 · see citing works

Somatic TP53 Mutations in the Era of Genome SequencingPreprint

Hainaut, P. L., & Pfeifer, G. P. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026179 · Cited by 247 · see citing works

Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR‐138 targets TERT and PD‐L1

Zhang, X., Xu, L., & Wang, F. (2017) · Cell Biology International · doi:10.1002/cbin.10826 · Cited by 241 · see citing works

SIGNOR: a database of causal relationships between biological entities

Perfetto, L., Briganti, L., Calderone, A., Perpetuini, A. C., Iannuccelli, M., Langone, F., Licata, L., Marinkovic, M., Mattioni, A., Pavlidou, T., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1048 · Cited by 235 · see citing works

Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy

Wang, H., Franco, F., & Ho, P. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.005 · Cited by 231 · see citing works

A Mitotic Phosphorylation Feedback Network Connects Cdk1, Plk1, 53BP1, and Chk2 to Inactivate the G2/M DNA Damage Checkpoint

van Vugt, M. A. T. M., Gardino, A. K., Linding, R., Ostheimer, G. J., Reinhardt, H. C., Ong, S.-E., Tan, C. S. H., Miao, H., Keezer, S. M., Li, J., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000287 · Cited by 228 · see citing works

Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma

Liu, Y., Patel, L. R., Mills, G. B., Lu, K. H., Sood, A. K., Ding, L., Kucherlapati, R., Mardis, E. R., Levine, D. A., Ilya Shmulevich, C., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju245 · Cited by 227 · see citing works

Exon 3 mutations of CTNNB1 drive tumorigenesis: a review

Gao, C., Wang, Y., Broaddus, R. R., Sun, L., Xue, F., & Zhang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.23695 · Cited by 223 · see citing works

Acetylation of β-Catenin by p300 Regulates β-Catenin-Tcf4 Interaction

Lévy, L., Yu, W., Labalette, C., Wu, Y., Renard, C.-A., Buendia, M. A., & Neuveut, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3404-3414.2004 · Cited by 220 · see citing works

Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript

Benelli, M., Pescucci, C., Marseglia, G., Severgnini, M., Torricelli, F., & Magi, A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts617 · Cited by 220 · see citing works

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells

Eggermont, L. J., Paulis, L. E. M., Tel, J., & Figdor, C. G. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.06.007 · Cited by 218 · see citing works

Steady-state Regulation of the Human DNA Mismatch Repair System

Chang, D. K., Ricciardiello, L., Goel, A., Chang, C. L., & Boland, C. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001140200 · Cited by 210 · see citing works

MASIC: A software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC–MS(/MS) features

Monroe, M. E., Shaw, J. L., Daly, D. S., Adkins, J., & Smith, R. D. (2008) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2008.02.006 · Cited by 202 · see citing works

Recurrent chimeric fusion RNAs in non-cancer tissues and cells

Babiceanu, M., Qin, F., Xie, Z., Jia, Y., Lopez, K., Janus, N., Facemire, L., Kumar, S., Pang, Y., Qi, Y., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw032 · Cited by 202 · see citing works

Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence

Inga, A., Storici, F., Darden, T. A., & Resnick, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8612-8625.2002 · Cited by 200 · see citing works

Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis

McConechy, M. K., Talhouk, A., Leung, S. C. Y., Chiu, D. S., Yang, W., Senz, J., Reha-Krantz, L. J., Lee, C., Huntsman, D. D., Gilks, C. B., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2233 · Cited by 192 · see citing works

Acetylation of β-Catenin by CREB-binding Protein (CBP)

Wolf, D., Rodova, M., Miska, E. A., Calvet, J. P., & Kouzarides, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201196200 · Cited by 186 · see citing works

Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis

Nikulenkov, F., Spinnler, C., Li, H., Tonelli, C., Shi, Y., Turunen, M. M., Kivioja, T., Ignatiev, I., Kel, A. E., Taipale, J., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.89 · Cited by 182 · see citing works

Protein Identification Using Customized Protein Sequence Databases Derived from RNA-Seq Data

Wang, X., Slebos, R. J. C., Wang, D., Halvey, P. J., Tabb, D. L., Liebler, D. C., & Zhang, B. (2012) · Journal of Proteome Research · doi:10.1021/pr200766z · Cited by 173 · see citing works

Plk1 overexpression induces chromosomal instability and suppresses tumor development

de Cárcer, G., Venkateswaran, S. V., Salgueiro, L., Bakkali, A. E., Somogyi, K., Rowald, K., Montañés-Agudo, P., Sanclemente, M., Escobar, B., Martino, A. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05429-5 · Cited by 168 · see citing works

The Oncofetal Protein IMP3

Zheng, W., Yi, X., Fadare, O., Liang, S. X., Martel, M., Schwartz, P. E., & Jiang, Z. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181483ff8 · Cited by 166 · see citing works

Large-scale profiling of microRNAs for The Cancer Genome Atlas

Chu, A., Robertson, G., Brooks, D., Mungall, A. J. J., Birol, İ., Coope, R., Ma, Y. P., Jones, S. J. M., & Marra, M. A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv808 · Cited by 165 · see citing works

DNA mismatch repair-induced double-strand breaks

Nowosielska, A., & Marinus, M. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.07.015 · Cited by 164 · see citing works

FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers

Tang, Y.-N., Shu, G., Yuan, X., Jing, N., & Song, J. (2010) · Cell Research · doi:10.1038/cr.2010.126 · Cited by 160 · see citing works

CTNNB1 mutations and β-catenin expression in endometrial carcinomas

Machín, P. F., Catasús, L., Pons, C., Muñoz, J., Matías‐Guiu, X., & Prat, J. (2002) · Human Pathology · doi:10.1053/hupa.2002.30723 · Cited by 152 · see citing works

Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) Suppress Cancer Cell Motility via Different Mechanisms

Ishii, H., Saitoh, M., Sakamoto, K., Kondo, T., Katoh, R., Tanaka, S., Motizuki, M., Masuyama, K., & Miyazawa, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589432 · Cited by 152 · see citing works

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Huang, K., Li, S., Mertins, P., Cao, S., Gunawardena, H. P., Ruggles, K. V., Mani, D. R., Clauser, K. R., Tanioka, M., Usary, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14864 · Cited by 146 · see citing works

Protein-structure-guided discovery of functional mutations across 19 cancer types

Niu, B., Scott, A. D., Sengupta, S., Bailey, M. H., Batra, P., Ning, J., Wyczalkowski, M. A., Liang, W.-W., Zhang, Q., McLellan, M. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3586 · Cited by 142 · see citing works

Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants

Xi, R., Lee, S., Xia, Y., Kim, T., & Park, P. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw491 · Cited by 138 · see citing works

Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT)

Warzecha, C. C., & Carstens, R. P. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.003 · Cited by 137 · see citing works

Vaccination with multiple peptides derived from novel cancer‐testis antigens can induce specific T‐cell responses and clinical responses in advanced esophageal cancer

Kono, K., Mizukami, Y., Daigo, Y., Takano, A., Masuda, K., Yoshida, K., Tsunoda, T., Kawaguchi, Y., Nakamura, Y., & Fujii, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01200.x · Cited by 134 · see citing works

Circular RNAs in Cancer – Lessons Learned From microRNAs

Dragomir, M. P., & Călin, G. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00179 · Cited by 134 · see citing works

INTEGRATE: gene fusion discovery using whole genome and transcriptome dataPreprint

Zhang, J., White, N. M. A., Schmidt, H. K., Fulton, R. S., Tomlinson, C., Warren, W. C., Wilson, R. K., & Maher, C. A. (2015) · Genome Research · doi:10.1101/gr.186114.114 · Cited by 126 · see citing works

PDV: an integrative proteomics data viewer

Li, K., Vaudel, M., Zhang, B., Ren, Y., & Wen, B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty770 · Cited by 126 · see citing works

Analysis of somatic microsatellite indels identifies driver events in human tumors

Maruvka, Y. E., Mouw, K. W., Karlić, R., Parasuraman, P., Kamburov, A., Polak, P. P., Haradhvala, N. J., Hess, J. M., Rheinbay, E., Brody, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3966 · Cited by 124 · see citing works

Identification of human leukocyte antigen‐A24‐restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy

Suda, T., Tsunoda, T., Daigo, Y., Nakamura, Y., & Tahara, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00603.x · Cited by 119 · see citing works

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

Ruggles, K. V., Tang, Z., Wang, X., Grover, H., Askenazi, M., Teubl, J., Cao, S., McLellan, M. D., Clauser, K. R., Tabb, D. L., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056226 · Cited by 118 · see citing works

Cyclin A-cdk1-Dependent Phosphorylation of Bora Is the Triggering Factor Promoting Mitotic Entry

Vigneron, S., Sundermann, L., Labbé, J., Pintard, L., Radulescu, O., Castro, A., & Lorca, T. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.05.005 · Cited by 118 · see citing works

Immunomic analysis of human sarcoma

Lee, S., Obata, Y., Yoshida, M., Stockert, E., Williamson, B., Jungbluth, A. A., Chen, Y., Old, L. J., & Scanlan, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437972100 · Cited by 114 · see citing works

Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types

Onuchic, V., Hartmaier, R. J., Boone, D. N., Samuels, M. L., Patel, R. Y., White, W., Garovic, V. D., Oesterreich, S., Roth, M. E., Lee, A. V., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.057 · Cited by 110 · see citing works

Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer

Kim, M., Zhang, Y., & Lozano, G. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00249 · Cited by 108 · see citing works

miR‐200/375 control epithelial plasticity‐associated alternative splicing by repressing the RNA‐binding protein Quaking

Pillman, K. A., Phillips, C. A., Roslan, S., Toubia, J., Dredge, B. K., Bert, A. G., Lumb, R., Neumann, D., Li, X., Conn, S. J., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899016 · Cited by 106 · see citing works

Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.

Bianchi, G., Borgonovo, G., Pistoia, V., & Raffaghello, L. (2011) · PubMed · doi:10.14670/hh-26.941 · Cited by 104 · see citing works

Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer

Tanaka, Y., Terai, Y., Kawaguchi, H., Fujiwara, S., Yoo, S., Tsunetoh, S., Takai, M., Kanemura, M., Tanabe, A., & Ohmichi, M. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.22625 · Cited by 102 · see citing works

Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasisPreprint

Li, C. M.-C., Gocheva, V., Oudin, M. J., Bhutkar, A. J., Wang, S. Y., Date, S. R., Ng, S. R., Whittaker, C. A., Bronson, R. T., Snyder, E. L., et al. (2015) · Genes & Development · doi:10.1101/gad.267393.115 · Cited by 98 · see citing works

PepQuery enables fast, accurate, and convenient proteomic validation of novel genomic alterationsPreprint

Wen, B., Wang, X., & Zhang, B. (2019) · Genome Research · doi:10.1101/gr.235028.118 · Cited by 97 · see citing works

DNA methylation in endometrial cancer

Tao, M. H., & Freudenheim, J. L. (2010) · Epigenetics · doi:10.4161/epi.5.6.12431 · Cited by 89 · see citing works

DNA damage checkpoint recovery and cancer development

Wang, H., Zhang, X., Teng, L., & Legerski, R. J. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.03.011 · Cited by 89 · see citing works

p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes

Pappas, K., Xu, J., Zairis, S., Resnick‐Silverman, L., Abate, F., Steinbach, N., Ozturk, S., Saal, L. H., Su, T., Cheung, P., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0089 · Cited by 75 · see citing works

The human DEPhOsphorylation database DEPOD: a 2015 update

Duan, G., Li, X., & Köhn, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1009 · Cited by 71 · see citing works

Not all p53 gain-of-function mutants are created equal

Mello, S. S., & Attardi, L. D. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.53 · Cited by 69 · see citing works

Proteomic analysis of cell cycle progression in asynchronous cultures, including mitotic subphases, using PRIMMUS

Ly, T., Whigham, A., Clarke, R. G., Murillo, A. B., Estes, B., Madhessian, D., Lundberg, E. K., Wadsworth, P., & Lamond, A. I. (2017) · eLife · doi:10.7554/elife.27574 · Cited by 68 · see citing works

Quantifying circular RNA expression from RNA-seq data using model-based framework

Li, M., Xie, X., Zhou, J., Sheng, M., Yin, X., Ko, E.-A., Zhou, T., & Gu, W. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx129 · Cited by 63 · see citing works

Wnt proteins synergize to activate β-catenin signaling

Alok, A., Lei, Z., Jagannathan, N. S., Kaur, S., Harmston, N., Rozen, S., Tucker-Kellogg, L., & Virshup, D. (2017) · Journal of Cell Science · doi:10.1242/jcs.198093 · Cited by 59 · see citing works

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

Depreeuw, J., Stelloo, E., Osse, E. M., Creutzberg, C. L., Nout, R. A., Moisse, M., Garcia-Dios, D. A., Dewaele, M., Willekens, K., Marine, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0566 · Cited by 59 · see citing works

Structural Basis of Restoring Sequence-Specific DNA Binding and Transactivation to Mutant p53 by Suppressor Mutations

Suad, O., Rozenberg, H., Brosh, R., Diskin‐Posner, Y., Kessler, N., Shimon, L. J. W., Frolow, F., Liran, A., Rotter, V., & Shakked, Z. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.063 · Cited by 56 · see citing works

Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

Mundt, F. O., Rajput, S., Li, S., Ruggles, K. V., Mooradian, A. D., Mertins, P., Gillette, M. A., Krug, K., Guo, Z., Hoog, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1990 · Cited by 56 · see citing works

Correcting systematic bias and instrument measurement drift with mzRefinery

Gibbons, B. C., Chambers, M., Monroe, M. E., Tabb, D. L., & Payne, S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv437 · Cited by 52 · see citing works

β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers

Myers, A. P., Barry, W. T., Hirsch, M. S., Matulonis, U. A., & Lee, L. J. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.010 · Cited by 51 · see citing works

Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts

Tabb, D. L., Wang, X., Carr, S. A., Clauser, K. R., Mertins, P., Chambers, M., Holman, J. D., Wang, J., Zhang, B., Zimmerman, L. J., et al. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00859 · Cited by 51 · see citing works

IMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid Adenocarcinoma

Mhawech-Fauceglia, P. Y., Herrmann, F. R., Rai, H., Tchabo, N. E., Lele, S., Izevbaye, I., Odunsi, K. O., & Cheney, R. T. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcpqdqxj4fnrfqb · Cited by 48 · see citing works

ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma

Krakstad, C., Tangen, I. L., Høivik, E. A., Halle, M. K., Berg, A., Werner, H. M. J., Raeder, M. B., Kusonmano, K., Zou, J. X., Oyan, A. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4955 · Cited by 47 · see citing works

The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma

Mizutani, A., Koinuma, D., Seimiya, H., & Miyazono, K. (2015) · Oncogene · doi:10.1038/onc.2015.412 · Cited by 47 · see citing works

FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer

Wang, B., Liu, G., Ding, L., Zhao, J., & Lu, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6157 · Cited by 44 · see citing works

Microsatellite instability derivedJAK1frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer

Stelloo, E., Versluis, M., Nijman, H. W., de Bruyn, M., Plat, A., Osse, E. M., van Dijk, R. H., Nout, R. A., Creutzberg, C. L., de Bock, G. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9414 · Cited by 43 · see citing works

Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells

Mukohyama, J., Shimono, Y., Minami, H., Kakeji, Y., & Suzuki, A. (2017) · Cancers · doi:10.3390/cancers9100143 · Cited by 40 · see citing works

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer

Umene, K., Yanokura, M., Banno, K., Irie, H., Adachi, M., Iida, M., Nakamura, K., Nogami, Y., Masuda, K., Kobayashi, Y., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2842 · Cited by 38 · see citing works

XRN2 promotes EMT and metastasis through regulating maturation of miR-10a

Zhang, H., Lü, Y., Chen, E., Li, X., Lv, B., Vikis, H. G., & Liu, P. (2017) · Oncogene · doi:10.1038/onc.2017.39 · Cited by 34 · see citing works

Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes

Thomas, S. N., Friedrich, B., Schnaubelt, M., Chan, D. W., Zhang, H., & Aebersold, R. H. (2020) · iScience · doi:10.1016/j.isci.2020.101079 · Cited by 34 · see citing works

SIRT1 Mediates FOXA2 Breakdown by Deacetylation in a Nutrient-Dependent Manner

van Gent, R., Sanza, C. D., van den Broek, N. J. F., Fleskens, V., Veenstra, A., Stout, G. J., & Brenkman, A. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098438 · Cited by 32 · see citing works

Microsatellite Instability, MLH1 Promoter Methylation, and Loss of Mismatch Repair in Endometrial Cancer and Concomitant Atypical Hyperplasia

Horowitz, N. S., Pinto, K. R., Mutch, D. G., Herzog, T. J., Rader, J. S., Gibb, R. K., Edmonston, T. B., & Goodfellow, P. J. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6724 · Cited by 29 · see citing works

Tackling molecular targets beyond PD-1/PD-L1: Novel approaches to boost patients’ response to cancer immunotherapy

Omar, H. A., & Tolba, M. F. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.009 · Cited by 28 · see citing works

A stringent requirement for Plk1 T210 phosphorylation during K-fiber assembly and chromosome congression

Paschal, C. R., Maciejowski, J., & Jallepalli, P. V. (2012) · Chromosoma · doi:10.1007/s00412-012-0375-8 · Cited by 27 · see citing works

Prostate Cancer: Any Room Left for Immunotherapies?

Baxevanis, C. N., Fortis, S. P., & Perez, S. A. (2019) · Immunotherapy · doi:10.2217/imt-2018-0159 · Cited by 18 · see citing works

Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?

Zhu, M., Jia, N., Huang, F., Liu, X., Zhao, Y., Tao, X., Jiang, W., Li, Q., & Feng, W. (2017) · BMC Cancer · doi:10.1186/s12885-017-3671-0 · Cited by 16 · see citing works

BlackSheep: A Bioconductor and Bioconda Package for Differential Extreme Value AnalysisPreprint

Blumenberg, L., Kawaler, E. A., Cornwell, M., Smith, S. A., Ruggles, K., & Fenyö, D. (2019) · bioRxiv · doi:10.1101/825067 · Cited by 16 · see citing works

Architects meets Repairers: the interplay between homeobox genes and DNA repair

Feltes, B. C. (2019) · DNA Repair · doi:10.1016/j.dnarep.2018.10.007 · Cited by 15 · see citing works

Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations

Meng, X., Yang, S., Li, Y., Li, Y., Devor, E. J., Bi, J., Wang, X., Umesalma, S., Quelle, D. E., Thiel, W. H., et al. (2018) · Disease Markers · doi:10.1155/2018/3810108 · Cited by 15 · see citing works

BlackSheep: A Bioconductor and Bioconda Package for Differential Extreme Value Analysis

Blumenberg, L. M., Kawaler, E. A., Cornwell, M., Smith, S. A., Ruggles, K. V., & Fenyö, D. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00190 · Cited by 15 · see citing works

Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers

Berg, A., Gulati, A., Ytre‐Hauge, S., Fasmer, K. E., Mauland, K. K., Høivik, E. A., Husby, J. A., Tangen, I. L., Trovik, J., Halle, M. K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19708 · Cited by 7 · see citing works

Orthogonal proteomic platforms and their implications for the stable classification of high-grade serous ovarian cancer subtypesPreprint

Thomas, S. N., Friedrich, B., Schnaubelt, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/793026 · Cited by 4 · see citing works

The emerging roles of circRNAs in cancer and oncology

Kristensen, L. S., Jakobsen, T., Hager, H., & Kjems, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00585-y · Cited by 1,256 · see citing works

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820 · see citing works

Endometrial cancer

Makker, V., MacKay, H. J., Ray-Coquard, I. L., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 705 · see citing works

Proteogenomic and metabolomic characterization of human glioblastoma

Wang, L.-B., Karpova, A., Gritsenko, M. A., Kyle, J. E., Cao, S., Li, Y., Rykunov, D., Colaprico, A., Rothstein, J. H., Hong, R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.006 · Cited by 661 · see citing works

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.023 · Cited by 578 · see citing works

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L. M., Karpova, A. Y., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.036 · Cited by 532 · see citing works

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

Dong, L., Lu, D., Chen, R., Lin, Y., Zhu, H., Zhang, Z., Cai, S., Cui, P., Song, G., Rao, D., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.12.006 · Cited by 400 · see citing works

Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities

Müller‐Dott, S., Tsirvouli, E., Vázquez, M., Flores, R. O. R., Badia-i-Mompel, P., Fallegger, R., Türei, D., Lægreid, A., & Sáez-Rodríguez, J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad841 · Cited by 404 · see citing works

Data‐Independent Acquisition Mass Spectrometry‐Based Proteomics and Software Tools: A Glimpse in 2020

Zhang, F.-F., Ge, W., Ruan, G., Cai, X., & Guo, T. (2020) · Proteomics · doi:10.1002/pmic.201900276 · Cited by 298 · see citing works

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

Petralia, F., Tignor, N., Reva, B., Koptyra, M., Chowdhury, S., Rykunov, D., Krek, A., Ma, W., Zhu, Y., Ji, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.044 · Cited by 317 · see citing works

Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer

Zhou, D. C., Jayasinghe, R. G., Chen, S., Herndon, J. M., Iglesia, M. D., Navale, P., Wendl, M. C., Caravan, W., Sato, K., Storrs, E. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01157-1 · Cited by 282 · see citing works

Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery

Kwon, Y. W., Jo, H.-S., Bae, S., Seo, Y., Song, P., Song, M., & Yoon, J. H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.747333 · Cited by 270 · see citing works

Proteogenomic data and resources for pan-cancer analysis

Li, Y., Dou, Y., Leprevost, F. D. V., Geffen, Y., Calinawan, A. P., Aguet, F., Akiyama, Y., Anand, S. K., Birger, C., Cao, S., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.06.009 · Cited by 260 · see citing works

Cancer proteogenomics: current impact and future prospects

Mani, D. R., Krug, K., Zhang, B., Satpathy, S., Clauser, K. R., Ding, L., Ellis, M., Gillette, M. A., & Carr, S. A. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00446-5 · Cited by 229 · see citing works

A high-stringency blueprint of the human proteome

Adhikari, S., Nice, E. C., Deutsch, E. W., Lane, L., Omenn, G. S., Pennington, S. R., Paik, Y.-K., Overall, C. M., Corrales, F. J., Cristea, I. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19045-9 · Cited by 210 · see citing works

Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways

Zhang, Y., Chen, F., Chandrashekar, D. S., Varambally, S., & Creighton, C. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30342-3 · Cited by 216 · see citing works

Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors

Roudko, V., Bozkus, C. C., Orfanelli, T., McClain, C. B., Carr, C. E., O’Donnell, T. J., Chakraborty, L., Samstein, R. M., Huang, K., Blank, S. V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.004 · Cited by 212 · see citing works

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Geffen, Y., Anand, S. K., Akiyama, Y., Yaron, T. M., Song, Y., Johnson, J. L., Govindan, A., Babur, Ö., Li, Y., Huntsman, E. M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.013 · Cited by 210 · see citing works

Epigenetic regulation during cancer transitions across 11 tumour types

Terekhanova, N. V., Karpova, A. Y., Liang, W.-W., Strzalkowski, A. J., Chen, S., Li, Y., Southard-Smith, A. N., Iglesia, M. D., Wendl, M. C., Jayasinghe, R. G., et al. (2023) · Nature · doi:10.1038/s41586-023-06682-5 · Cited by 205 · see citing works

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Rodriguez, H., Zenklusen, J. C., Staudt, L. M., Doroshow, J. H., & Lowy, D. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.055 · Cited by 190 · see citing works

Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers

Park, H., Kim, J.-W., & Baek, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113904 · Cited by 166 · see citing works

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

Pataskar, A., Champagne, J., Nagel, R., Kenski, J. C. N., Laos, M., Michaux, J., Pak, H. S., Bleijerveld, O. B., Mordente, K., Navarro, J. M., et al. (2022) · Nature · doi:10.1038/s41586-022-04499-2 · Cited by 146 · see citing works

The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance

Joshi, S. K., Nechiporuk, T., Bottomly, D., Piehowski, P., Reisz, J. A., Pittsenbarger, J., Kaempf, A. J., Gosline, S. J. C., Wang, Y.-T., Hansen, J., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.06.003 · Cited by 149 · see citing works

PTM-Shepherd: Analysis and Summarization of Post-Translational and Chemical Modifications From Open Search Results

Geiszler, D., Kong, A. T., Avtonomov, D. M., Yu, F., Leprevost, F. D. V., & Nesvizhskii, A. I. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir120.002216 · Cited by 147 · see citing works

A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population

Qu, Y., Feng, J., Wu, X., Bai, L., Xu, W., Zhu, L., Liu, Y., Xu, F., Zhang, X., Yang, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29577-x · Cited by 139 · see citing works

Predicting endometrial cancer subtypes and molecular features from histopathology images using multi-resolution deep learning models

Hong, R., Liu, W., DeLair, D., Razavian, N., & Fenyö, D. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100400 · Cited by 154 · see citing works

Quantitative Proteomics Using Isobaric Labeling: A Practical Guide

Chen, X., Sun, Y., Zhang, T., Shu, L., Roepstorff, P., & Yang, F. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.012 · Cited by 126 · see citing works

Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis

la Rubia, E. C.-D., Martínez-García, E., Dittmar, G. A. G., Gil‐Moreno, A., Cabrera, S., & Colás, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061900 · Cited by 125 · see citing works

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

Kramer, M. H., Zhang, Q., Sprung, R. W., Day, R. B., Erdmann-Gilmore, P., Li, Y., Xu, Z., Helton, N., George, D. R., Mi, Y., et al. (2022) · Blood · doi:10.1182/blood.2022016033 · Cited by 122 · see citing works

CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner

Liu, X., Liu, Y., Liu, Z., Lin, C., Meng, F., Xu, L., Zhang, X., Zhang, C., Zhang, P., Gong, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01412-9 · Cited by 119 · see citing works

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Lehtiö, J., Arslan, T., Siavelis, I., Pan, Y., Socciarelli, F., Berkovska, O., Umer, H. M., Mermelekas, G., Pirmoradian, M., Jönsson, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00259-9 · Cited by 115 · see citing works

Pan-cancer proteogenomics connects oncogenic drivers to functional states

Li, Y., Porta‐Pardo, E., Tokheim, C. J., Bailey, M. H., Yaron, T. M., Stathias, V., Geffen, Y., Imbach, K. J., Cao, S., Anand, S. K., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.014 · Cited by 114 · see citing works

Integrated proteogenomic characterization of glioblastoma evolution

Kim, K., Migliozzi, S., Koo, H., Hong, J.-H., Park, S. M., Kim, S., Kwon, H. J., Ha, S., Garofano, L., Oh, Y. T., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.015 · Cited by 111 · see citing works

Moving pan-cancer studies from basic research toward the clinic

Chen, F., Wendl, M. C., Wyczalkowski, M. A., Bailey, M. H., Li, Y., & Ding, L. (2021) · Nature Cancer · doi:10.1038/s43018-021-00250-4 · Cited by 107 · see citing works

LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint

McKerrow, W., Wang, X., Mendez‐Dorantes, C., Mita, P., Cao, S., Grivainis, M., Ding, L., LaCava, J., Burns, K. H., Boeke, J. D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115999119 · Cited by 107 · see citing works

Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

Liang, W.-W., Lu, R. J.-H., Jayasinghe, R. G., Foltz, S. M., Porta-Pardo, E., Geffen, Y., Wendl, M. C., Lazcano, R., Kolodziejczak, I., Song, Y., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.013 · Cited by 105 · see citing works

Untargeted metabolomics analysis of esophageal squamous cell cancer progression

Yang, T., Hui, R., Nouws, J., Sauler, M., Zeng, T., & Wu, Q. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03311-z · Cited by 101 · see citing works

Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential

Strepkos, D., Markouli, M., Κλώνου, Α., Papavassiliou, A. G., & Piperi, C. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2906 · Cited by 97 · see citing works

Pan-cancer proteogenomics characterization of tumor immunity

Petralia, F., Ma, W., Yaron, T. M., Caruso, F. P., Tignor, N. L., Wang, J. M., Charytonowicz, D., Johnson, J. L., Huntsman, E. M., Marino, G. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.027 · Cited by 96 · see citing works

Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer

Wang, Y.-T., Shi, T., Srivastava, S., Kagan, J., Liu, T., & Rodland, K. (2020) · Cancers · doi:10.3390/cancers12092335 · Cited by 88 · see citing works

Lynch Syndrome and MSI-H Cancers: From Mechanisms to “Off-The-Shelf” Cancer Vaccines

Roudko, V., Bozkus, C. C., Greenbaum, B. D., Lucas, A. L., Samstein, R. M., & Bhardwaj, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757804 · Cited by 86 · see citing works

CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer

Zhang, J., Chen, S., Wei, S., Cheng, S., Shi, R., Zhao, R., Zhang, W., Zhang, Q., Teng, H., Feng, D., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102493 · Cited by 87 · see citing works

Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies

Yang, Y., Wu, S. F., & Bao, W. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14969 · Cited by 89 · see citing works

Current and Emerging Prognostic Biomarkers in Endometrial Cancer

Njoku, K., Barr, C. E., & Crosbie, E. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.890908 · Cited by 87 · see citing works

Experimental reproducibility limits the correlation between mRNA and protein abundances in tumor proteomic profiles

Upadhya, S. R., & Ryan, C. J. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100288 · Cited by 81 · see citing works

A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes

Wang, T.-Y., Liu, Q., Ren, Y., Alam, S. K., Wang, L., Zhu, Z., Hoeppner, L. H., Dehm, S. M., Cao, Q., & Yang, R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.028 · Cited by 74 · see citing works

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma

Gu, C., Wang, W., Tang, X., Xu, T., Zhang, Y., Guo, M., Wei, R., Wang, Y., Jurczyszyn, A. J., Janz, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01380-0 · Cited by 70 · see citing works

SETDB1 in cancer: overexpression and its therapeutic implications.

Lazaro-Camp, V. J., Salari, K., Meng, X., & Yang, S. (2021) · PubMed Central · Cited by 70 · see citing works

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability

Tang, X., Guo, M., Ding, P., Deng, Z., Ke, M., Yuan, Y., Zhou, Y., Lin, Z., Li, M., Gu, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00746-6 · Cited by 68 · see citing works

Wnt Signaling in Gynecologic Malignancies

McMellen, A. N., Woodruff, E. R., Corr, B. R., Bitler, B. G., & Moroney, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124272 · Cited by 66 · see citing works

Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management

Dörk, T., Hillemanns, P., Tempfer, C. M., Breu, J., & Fleisch, M. C. (2020) · Cancers · doi:10.3390/cancers12092407 · Cited by 66 · see citing works

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues

Abelin, J. G., Bergstrom, E. J., Rivera, K. D., Taylor, H. B., Klaeger, S., Xu, C., Verzani, E. K., White, C. J., Woldemichael, H. B., Virshup, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37547-0 · Cited by 61 · see citing works

Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer

Campeanu, I. J., Jiang, Y., Liu, L., Pilecki, M., Najor, A., Cobani, E., Manning, M., Zhang, X. M., & Yang, Z.-Q. (2021) · Scientific Reports · doi:10.1038/s41598-021-94019-5 · Cited by 62 · see citing works

Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer

Yin, W., Fuchun, L., Chen, M., Xiaoqing, Q., Hao, L., Yuan, L., & Desheng, Y. (2021) · Aging · doi:10.18632/aging.203190 · Cited by 60 · see citing works

Molecular mechanisms of psychiatric diseases

Blokhin, I. O., Khorkova, O., Saveanu, R. V., & Wahlestedt, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105136 · Cited by 58 · see citing works

Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides

Ferreira, H. J., Stevenson, B. J., Pak, H., Yu, F., Oliveira, J., Huber, F., Taillandier-Coindard, M., Michaux, J., Altimiras, E. R., Kraemer, A. I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46408-3 · Cited by 58 · see citing works

RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets

Pan, Y., Kadash-Edmondson, K. E., Wang, R., Phillips, J., Liu, S., Ribas, A., Aplenc, R., Witte, O. N., & Xing, Y. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.006 · Cited by 59 · see citing works

A proteogenomics data-driven knowledge base of human cancer

Liao, Y., Savage, S. R., Dou, Y., Shi, Z., Yi, X., Jiang, W., Lei, J. T., & Zhang, B. (2023) · Cell Systems · doi:10.1016/j.cels.2023.07.007 · Cited by 56 · see citing works

A multi‐omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma

Jin, X., Liu, L., Jia Rui, W. U., Jin, X., Yu, G., Jia, L., Wang, F., Shi, M., Lu, H., Liu, J., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.538 · Cited by 55 · see citing works

Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy

Xing, X., Hu, E., Ouyang, J., Zhong, X., Wang, F., Liu, K., Cai, L., Zhou, Y., Wang, Y., Chen, G., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101315 · Cited by 55 · see citing works

Facts and Hopes in Immunotherapy of Endometrial Cancer

Marín‐Jiménez, J. A., García‐Mulero, S., Matías‐Guiu, X., & Piulats, J. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1564 · Cited by 54 · see citing works

Proteogenomic insights suggest druggable pathways in endometrial carcinoma

Dou, Y., Katsnelson, L., Gritsenko, M., Hu, Y., Reva, B. A., Hong, R., Wang, Y.-T., Kołodziejczak, I., Lu, R. J.-H., Tsai, C., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.007 · Cited by 54 · see citing works

VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms

Zhang, K., Zakeri, A., Alban, T. J., Dong, J., Ta, H. M., Zalavadia, A. H., Branicky, A., Zhao, H., Jurić, I., Husic, H., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113661 · Cited by 52 · see citing works

Structure, Activity and Function of the SETDB1 Protein Methyltransferase

Markouli, M., Strepkos, D., & Piperi, C. (2021) · Life · doi:10.3390/life11080817 · Cited by 49 · see citing works

Mass spectrometry-based targeted proteomics for analysis of protein mutations

Lin, T.-T., Zhang, T., Kitata, R. B., Liu, T., Smith, R. D., Qian, W., & Shi, T.-J. (2021) · Mass spectrometry reviews (Print) · doi:10.1002/mas.21741 · Cited by 44 · see citing works

CircRNAs regulate the crosstalk between inflammation and tumorigenesis: The bilateral association and molecular mechanisms

Qadir, J., Wen, S.-Y., Yuan, H., & Yang, B. B. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.12.005 · Cited by 50 · see citing works

Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer

Qin, M., Hamanishi, J., Ukita, M., Yamanoi, K., Takamatsu, S., Abiko, K., Murakami, R., Miyamoto, T., Suzuki, H., Ueda, A., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03093-1 · Cited by 50 · see citing works

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?

Aldea, M. D., Friboulet, L., Apcher, S., Jaulin, F., Mosele, F., Sourisseau, T., Soria, J., Nikolaev, S. I., & André, F. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101642 · Cited by 51 · see citing works

Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities

Chang, L., Jung, N. Y., Atari, A., Rodriguez, D. J., Kesar, D., Song, T., Rees, M. G., Ronan, M. M., Li, R., Ruiz, P. A., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01515-7 · Cited by 45 · see citing works

The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers

Dong, P., Xu, D., Xiong, Y., Yue, J., Ihira, K., Konno, Y., & Watari, H. (2020) · Cancers · doi:10.3390/cancers12061472 · Cited by 46 · see citing works

Human-Derived Model Systems in Gynecological Cancer Research

Lõhmussaar, K., Boretto, M., & Clevers, H. C. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.07.007 · Cited by 46 · see citing works

Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling

López‐Janeiro, Á., Ruz‐Caracuel, I., Ramón-Patiño, J. L., Rı́os, V. D. L., Villalba-Esparza, M., Berjón, A., Yébenes, L., Hernández, A., Masetto, I., Kadioglu, E., et al. (2021) · Cancers · doi:10.3390/cancers13040794 · Cited by 46 · see citing works

Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma

Zhu, H.-W., Lin, Y.-P., Lu, D.-Y., Wang, S., Liu, Y., Dong, L.-Q., Meng, Q., Gao, J., Wang, Y., Song, N., et al. (2023) · National Science Review · doi:10.1093/nsr/nwad167 · Cited by 40 · see citing works

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma

Ruz‐Caracuel, I., López‐Janeiro, Á., Heredia-Soto, V., Ramón-Patiño, J. L., Yébenes, L., Berjón, A., Hernández, A., Gallego, A., Ruiz, P., Redondo, A., et al. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03176-5 · Cited by 45 · see citing works

Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics

Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-03048-y · Cited by 43 · see citing works

Global impact of somatic structural variation on the cancer proteome

Chen, F., Zhang, Y., Chandrashekar, D. S., Varambally, S., & Creighton, C. J. (2023) · Nature Communications · doi:10.1038/s41467-023-41374-8 · Cited by 42 · see citing works

Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Wang, J. M., Hong, R., Demicco, E. G., Tan, J., Lazcano, R., Moreira, A. L., Li, Y., Calinawan, A. P., Razavian, N., Schraink, T., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101173 · Cited by 41 · see citing works

LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer

Zhan, L., Zhang, J., Zhang, J., Liu, X., Zhu, S., Shi, Y., He, Y., Wang, W., Fan, Y., Tang, Z., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.031 · Cited by 41 · see citing works

Simplified and Unified Access to Cancer Proteogenomic Data

Lindgren, C. M., Adams, D. W., Kimball, B., Boekweg, H., Tayler, S., Pugh, S. L., & Payne, S. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00919 · Cited by 40 · see citing works

TRF-20-M0NK5Y93 suppresses the metastasis of colon cancer cells by impairing the epithelial-to-mesenchymal transition through targeting Claudin-1.

Luan, N., Chen, Y., Li, Q., Mu, Y., Zhou, Q., Ye, X., Deng, Q., Ling, L., Wang, J., & Wang, J. (2021) · Europe PMC (PubMed Central) · Cited by 40 · see citing works

Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers

Monsivais, D., Vasquez, Y. M., Chen, F., Zhang, Y., Chandrashekar, D. S., Faver, J. C., Masand, R. P., Scheurer, M. E., Varambally, S., Matzuk, M. M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01681-0 · Cited by 40 · see citing works

Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens

Xiang, R., Ma, L., Yang, M., Zheng, Z., Chen, X., Jia, F., Xie, F., Zhou, Y., Li, F., Wu, K., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02007-2 · Cited by 42 · see citing works

The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients

López‐Janeiro, Á., Villalba-Esparza, M., Brizzi, M. E., Jiménez‐Sánchez, D., Ruz‐Caracuel, I., Kadioglu, E., Masetto, I., Goubert, V., García-Ros, D., Melero, I., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6012 · Cited by 39 · see citing works

Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1

Liu, D., Li, M., Zhao, Z., Zhou, L., Zhi, F., Guo, Z., & Cui, J. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3971 · Cited by 40 · see citing works

Single-cell transcriptome profiles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identifies specific sensitive drugs

Ren, F., Wang, L., Wang, Y., Wang, J., Wang, Y., Song, X., Zhang, G., Nie, F., & Lin, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06960-8 · Cited by 43 · see citing works

Computational Analysis of Phosphoproteomics Data in Multi‐Omics Cancer Studies

Mantini, G., Pham, T. V., Piersma, S. R., & Jiménez, C. R. (2020) · PROTEOMICS · doi:10.1002/pmic.201900312 · Cited by 38 · see citing works

miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma

Lu, X., Li, J., Liu, S., Wang, H., & Chen, B. (2022) · International Journal of Endocrinology · doi:10.1155/2022/5006123 · Cited by 38 · see citing works

Proteomic workflows for high-quality quantitative proteome and post-translational modification analysis of clinically relevant samples from formalin-fixed paraffin-embedded archives

Kuras, M., Woldmar, N., Kim, Y., Hefner, M., Malm, J., Moldvay, J., Döme, B., Fillinger, J., Pizzatti, L., Gil, J., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00850 · Cited by 36 · see citing works

Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes

Thomas, S. N., Friedrich, B., Schnaubelt, M., Chan, D. W., Zhang, H., & Aebersold, R. H. (2020) · iScience · doi:10.1016/j.isci.2020.101079 · Cited by 34 · see citing works

Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy

Li, M., Wang, Y., Wu, P., Zhang, S., Gong, Z., Liao, Q., Guo, C., Wang, F., Li, Y., Zeng, Z., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216190 · Cited by 34 · see citing works

Extracellular vesicles secreted by adenomyosis endometrial organoids contain miRNAs involved in embryo implantation and pregnancy

Juárez‐Barber, E., Segura-Benítez, M., Carbajo‐García, M. C., Bas-Rivas, A., Faus, A., Vidal, C., Gilés, J., Labarta, E., Pellicer, A., Cervelló, I., et al. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.12.008 · Cited by 34 · see citing works

Protein prediction models support widespread post-transcriptional regulation of protein abundance by interacting partners

Srivastava, H., Lippincott, M. J., Currie, J., Canfield, R., Lam, M. P. Y., & Lau, E. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010702 · Cited by 34 · see citing works

Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment

Ma, J., Zhang, J., Yang, D., & Ma, X. (2020) · Aging · doi:10.18632/aging.104083 · Cited by 33 · see citing works

Mapping oncogenic protein interactions for precision medicine

Tabar, M. S., Francis, H., Yeo, D., Bailey, C. G., & Rasko, J. E. J. (2022) · International Journal of Cancer · doi:10.1002/ijc.33954 · Cited by 30 · see citing works

A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights

Yu, J. X., Gui, X., Zou, Y., Liu, Q., Yang, Z., An, J., Guo, X., Wang, K., Guo, J., Huang, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53830-0 · Cited by 33 · see citing works

Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact

Venetis, K., Frascarelli, C., Bielo, L. B., Cursano, G., Adorisio, R., Ivanova, M. D., Mane, E., Peruzzo, V., Concardi, A., Negrelli, M., et al. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115233 · Cited by 32 · see citing works

A tissue-specific atlas of protein–protein associations enables prioritization of candidate disease genes

Trip, D. S. L., van Oostrum, M., Memon, D., Frommelt, F., Baptista, D., Panneerselvam, K., Bradley, G., Licata, L., Hermjakob, H., Orchard, S. E., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02659-z · Cited by 39 · see citing works

Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer

Cai, L., Hu, C., Yu, S., Liu, L., Zhao, J., Zhao, Y., Lin, F. Y., Du, X., Yu, Q., & Xiao, Q. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.582274 · Cited by 32 · see citing works

Proteogenomics-based functional genome research: approaches, applications, and perspectives in plants

Song, Y., Das, D., Zhang, Y., Chen, M., Fernie, A. R., Zhu, F., & Han, J. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.05.010 · Cited by 34 · see citing works

Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes

Buttigieg, M. M., Vlasschaert, C., Bick, A. G., Vanner, R. J., & Rauh, M. J. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101989 · Cited by 29 · see citing works

Abstract 6580: Proteogenomic characterization of endometrial carcinoma

Kawaler, E. A., Dou, Y., Zhou, D. C., Gritsenko, M. A., Rodland, K., Ding, L., Zhang, B., Liu, T., & Fenyö, D. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-6580 · Cited by 5 · see citing works

Abstract 955: Proteogenomic insights suggest druggable pathways in endometrial cancer

Katsnelson, L., Dou, Y., Gritsenko, M. A., Anderson, M. L., Rodland, K., Zhang, B., Liu, T., & Fenyö, D. (2023) · Cancer Research · doi:10.1158/1538-7445.am2023-955

Proteogenomic insights suggest druggable pathways in endometrial carcinoma

Dou, Y., Katsnelson, L., Gritsenko, M., Hu, Y., Reva, B. A., Hong, R., Wang, Y.-T., Kołodziejczak, I., Lu, R. J.-H., Tsai, C., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.007 · Cited by 54 · see citing works

Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach

Taylor, A. H., Konje, J. C., & Ayakannu, T. (2023) · Cancers · doi:10.3390/cancers15184665 · Cited by 6 · see citing works

Integrated genomic characterization of endometrial carcinoma

The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784 · see citing works